loader

World Tenders & Procurement Opportunities

Search
Advanced Search

Notice of Intent to Publish a Notice of Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

World Biggest Tenders Source

This tender with title Notice of Intent to Publish a Notice of Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) has been published on Bidding Source portal dated 26 Jul 2023 for the country of United States. It has been categorized on Other therapeutic products & Medicinal products for the nervous system & Medicinal products for the nervous system and sensory organs & Other nervous system medicinal products. For similar tenders you can see tenders mentioned below of this page.

General Information

United States

Notice of Intent to Publish a Notice of Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
Invitation for Bids
NOT-NS-23-091
United States
26 Jul 2023
English
Other therapeutic products , Medicinal products for the nervous system , Medicinal products for the nervous system and sensory organs , Other nervous system medicinal products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

FDA Licensed Ebola Virus Therapeutics - BARDA-CBRN-022026 -- 6505 - DRUGS AND BIOLOGICALS United States Drug Target Analysis in the Human Central Nervous System - FDASB75F40124Q00344 -- AN41 - HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH United States Drug Target Analysis in the Human Central Nervous System - FDASBRFP75F40124Q00344 -- AN41 - HEALTH R&D SERVICES; HEALTH CARE - OTHER; BASIC RESEARCH United States Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required) United States Notice of Intent to Publish a Notice of Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional) United States Awarded - Medicinal product Calcium polystyrene sulfonate - 512186 -- <b>Contract Value: 2 970,00 EUR</b> Lithuania Medicinal products for the nervous system – Supply of medicines - Antidepressants and Neuroleptics - 513549 Belgium Other therapeutic products – LP s obsahem asciminibu 2026 - 506612 Czech Republic Awarded - SUPPLY OF MEDICINES_VUTRISIRANUM_PNS FOR DIAGNOSTIC AND TREATMENT FOR RARE DISEASES AND SEVERE SEPSIS_DEGENERATIVE/INFLAMMATORY-IMMUNOLOGICAL DISEASES_Drug treatment of patients with transthyretin amyloidosis - 497478 Romania Awarded - Tender for the supply of Medical Liquid Oxygen, Medical Gaseous Oxygen and Medical Liquefied Nitrous Oxide for the Needs of the Hospitals of OKYPY - 487059 Cyprus
Other therapeutic products Tenders
Medicinal products for the nervous system Tenders
Medicinal products for the nervous system and sensory organs Tenders
Other nervous system medicinal products Tenders
United States Tenders
North America Tenders
Tenders
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans